IFCC - Scientific Division (SD)
SD-Executive Committee:
From left to
right:
Dr. Heinz Schimmel -
IRMM Rep., Dr. Gary Myers - EC Secretary,
Prof. Mathias Müller - JCTLM Rep., Dr.
Christa M. Cobbaert, EC Member, Dr. David Bunk
- NIST Rep. - Prof. Ian Young - SD Chair,
Mr. Joseph Passarelli, Corporate Rep. (Roche),
Dr. Naotaka Hamasaki - EC Member,
Prof. Philippe Gillery - SD Vice-Chair - Ms. Paola
Bramati, IFCC Office
The Scientific Division (SD)
A Committee on Standards was established in 1966 "to instigate
and promote theoretical and practical developments in the field of
standards and standardisation in clinical chemistry - in its
broadest sense." During its first decade, the main efforts of the
Committee were directed toward analytical nomenclature, reference
materials and methods, and quality control. Its achievements during
this period are illustrated by the list of publications on these
topics. Following a Council decision in 1978, efforts have been
made to extend its work to include more subjects of interest both
to clinicians and clinical chemists. Accordingly, the name of the
Committee was changed to the Scientific Committee and later to the
Scientific Division.
Mission Statement
The mission of the SD is to advance the science of Clinical
Chemistry and to apply it to the practice of Clinical Laboratory
Medicine.
SD Strategy
According to the Statutes of IFCC, the Federation exists to
advance the science and practice of Clinical Chemistry and to
further its application in the provision of health services and the
practice of medicine. The goals to which the Scientific Division is
committed are to:
- Identify research areas of relevance to Clinical Chemistry and
Laboratory Medicine and assist the transfer of research results to
the profession.
- Identify scientific and technological problems in current
practice and provide solutions and guidelines on how to resolve
them.
- Facilitate the development and transfer of technical
innovations to clinical laboratory professionals and
clinicians.
- Facilitate the development and implementation of diagnostic
strategies.
- Establish standards for scientific and technical aspects of
good laboratory practice.
- Respond to scientific and technical needs of IFCC Member
Societies, IFCC Corporate Members and external agencies.
- Participate actively in the scientific programs of IFCC
congresses and other scientific meetings.
- Ensure the quality of IFCC scientific documents.
- Organise Master Discussions.
SD Projects
The SD initiates and manages projects with its own resources or
through its Committees and Working Groups. Work is conducted in
cooperation with other IFCC units and with relevant National and
International Organisations. The SD ensures that each of its
Committees and Working Groups are functioning under clear terms of
reference together with an agreed schedule of activity. The SD will
assist in the development of the project proposals, and will
undertake an annual review of progress and review and approve any
documents that result from the work.
SD Executive Committee (SD-EC)
|
Name |
Position |
Country |
Term |
Time in
Office |
| I. Young |
Chair |
UK |
1st |
2011 01 - 2013 12 |
| P. Gillery |
Vice-Chair |
FR |
1st |
2011 01 - 2013 12 |
| G. Myers |
Secretary |
US |
2nd |
2012 01 - 2014 12 |
| C.M. Cobbaert |
Member |
NL |
1st |
2012 01 - 2014 12 |
| N. Hamasaki |
Member |
JP |
2nd |
2012 01 - 2014 12 |
| G. Merlini |
Member |
IT |
1st |
2011 01 - 2013 12 |
| J. Passarelli |
Corporate Rep |
US |
2nd |
2013 01 - 2015 12 |
| H. Schimmel |
IRMM Consultant |
BE |
| D. Bunk |
NIST Consultant |
US |
| M.M. Müller |
SD Consultant/Chair JCTLM |
AT |
CHAIRS OF SCIENTIFIC DIVISION COMMITTEES AND WORKING
GROUPS
Executive Committee
SD Executive Committee: I. Young (UK)
Committees
| 8.2.6. |
Nomenclature, Properties and Units
(C-NPU) in collaboration with International Union of Pure and
Applied Chemistry (IUPAC) |
R. Flatman (AU) |
| 8.2.11. |
Molecular Diagnostics (C-MD) |
M. Pazzagli (IT) |
| 8.2.21. |
Reference Systems of Enzymes (C-RSE) |
F. Ceriotti (IT) |
| 8.2.23. |
Traceability in Laboratory Medicine (C-TLM) |
A. Kessler (DE) |
| 8.2.24. |
Reference Intervals and Decision Limits
(C-RIDL) |
K. Ichihara (JP) |
| 8.2.25. |
Thyroid Function Tests (C-STFT) |
L. Thienpont (BE) |
Committees
| 8.3.35. |
Standardisation of Hemoglobin A2
(WG-HbA2) |
R. Paleari (IT) |
| 8.3.36 |
Standardisation of Carbohydrate-Deficient
Transferrin (WG-CDT) |
F. Schellenberg (FR) |
| 8.3.39. |
Standardisation of Albumin Assay in
Urine (WG-SAU) in collaboration with National Kidney Disease
Education Program (NKDEP) |
G. Miller (USA) |
| 8.3.40. |
Standardisation of Pregnancy-Associated Plasma
Protein A (WG-PAPP A) |
K. Pettersson (FI) |
| 8.3.42. |
Standardisation of Insulin Assays (WG-SIA) in
collaboration with American Diabetes Association (ADA) and European
Association for the Study of Diabetes (EASD) |
M. Steffes (US) |
| 8.3.43. |
Standardisation of Troponin I (WG-TNI) |
J. Tate (AU) |
| 8.3.44. |
Allowable Errors for Traceable Results
(WG-AETR) |
R. Bais (AU) |
| 8.3.45 |
Harmonisation of Autoantibody Tests (WG-HAT) |
J. Sheldon (UK) |
| 8.3.46 |
Quality Specifications for Glucose POCT
(WG-GPOCT) |
R. Tirimacco (AU) |
| 8.3.47 |
Clinical Quantitative Mass Spectrometry Proteomics
(WG-cMSP) |
S. Lehmann (FR) |
| 8.3.48. |
Parathyroid Hormone (WG-PTH) |
C. Sturgeon (UK) |
| 8.3.49. |
CSF Proteins (WG-CSF) |
K. Blennow (SE) |
| 8.3.50. |
Standardisation of Bone Markers Assays
(WG-BMA) |
H. Morris (AU) |
SD Executive Committe's contacts
Prof. Ian S.YOUNG
Wellcome Research Laboratories
Top Floor ICS A Block
Royal Victoria Hospital
Grosvenor Road
Belfast BT12 6BJ
Northern Ireland, UK
Tel: +44 2890 632743
E-mail: I.Young@qub.ac.uk |
Mr. Joseph PASSARELLI
Roche Diagnostics GmbH
XR-H
Nonnenwald 2
82377 Penzberg
Germany
Tel: +49 8856 60 5743
Fax: +49 8856 60 4583
E-mail: joseph.passarelli@roche.com |
Prof. Philippe GILLERY
Laboratoire de Biologie et de
Recherche Pédiatriques
American Memorial Hospital
CHU de Reims
47 Rue Cognacq Jay
51092 Reims Cedex
France
Tel: +33 3 2678 3952
Fax: +33 3 2678 3882
E-mail: pgillery@chu-reims.fr |
Prof. Naotaka HAMASAKI
The Faculty of Pharmaceutical Science
Nagasaki International University
2825-7 Huis Ten Bosch
Sasebo Nagasaki, 859-3298
Japan
Tel: +81-956-20-5662; 81-956-39-2020
Fax: +81-956-39-3111
E-mail: hamasaki-nao@niu.ac.jp |
Dr. Gary L. MYERS
AACC
VP, Programs and Policy
1850 K Street, Suite 625
Washington, DC 20006-2215
USA
Telephone: (202) 835-0717 X1606
Fax: (202) 887-5093
E-mail: gmyers@aacc.org |
Dr. Heinz SCHIMMEL
European Commission - JRC - IRMM
Retieseweg 111
2440 Geel
Belgium
Tel: +32 14 571720
Fax: +32 14 590406
E-mail: Heinz.SCHIMMEL@ec.europa.eu |
|
Dr. Christa M. COBBAERT
Clinical Chemist Head of the
Department of Clinical Chemistry
Leiden University Medical Center
Postbus 9600
Postzone E2-P 2300
RC Leiden
The Netherlands
Tel: +31 71 5262278/+31 71 5264483
Fax : +31 71 52666753
E-mail: C.M.Cobbaert@lumc
|
Dr. David BUNK
Chemical Science and Technology
Laboratory
National Institute of Standards and
Technology
100 Bureau Drive
MS 8392
Gaithersburg MD 20899-8392
USA
Tel: +1 301 975 5071
Fax: +1 301 977 0685
E-mail: david.bunk@nist.gov |
Prof. Giampaolo MERLINI
Biotechnology Research Laboratory
Clinical Chemistry Central Laboratory
Foundation IRCCS Policlinico San Matteo
Department of Biochemistry, University of Pavia
P.le Golgi, 2
27100 Pavia
Italy
Tel:+39 0382 502 995
Fax:+39 0382 502 990
E-mail: gmerlini@unipv.it |
Prof. Mathias M. MÜLLER
Austrian Society of Quality Assurance
and Standardisation
Hörlgasse 18/5
1090 Wien
Austria
Tel: +43 1 319 88 95
Fax: +43 1 319 88 97
E-mail: mathias.mueller@oequasta.at |